Targeted α-therapy of metastatic castration-resistant prostate cancer with 225Ac-PSMA-617: swimmer-plot analysis suggests efficacy regarding duration of tumor control
The aim of this evaluation was to identify the first indicators of efficacy for 225Ac-labeled prostate-specific membrane antigen (PSMA)-617 therapy in a retrospectively analyzed group of patients.
Gespeichert in:
| Hauptverfasser: | , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
Jan. 11, 2018
|
| In: |
Journal of nuclear medicine
Year: 2018, Jahrgang: 59, Heft: 5, Pages: 795-802 |
| ISSN: | 2159-662X |
| DOI: | 10.2967/jnumed.117.203539 |
| Online-Zugang: | Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.2967/jnumed.117.203539 Verlag, lizenzpflichtig, Volltext: http://jnm.snmjournals.org/content/59/5/795 
|
| Verfasserangaben: | Clemens Kratochwil, Frank Bruchertseifer, Hendrik Rathke, Markus Hohenfellner, Frederik L. Giesel, Uwe Haberkorn, and Alfred Morgenstern |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1694741257 | ||
| 003 | DE-627 | ||
| 005 | 20230427070527.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200416s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2967/jnumed.117.203539 |2 doi | |
| 035 | |a (DE-627)1694741257 | ||
| 035 | |a (DE-599)KXP1694741257 | ||
| 035 | |a (OCoLC)1341315436 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Kratochwil, Clemens |d 1978- |e VerfasserIn |0 (DE-588)134026276 |0 (DE-627)559871686 |0 (DE-576)300262787 |4 aut | |
| 245 | 1 | 0 | |a Targeted α-therapy of metastatic castration-resistant prostate cancer with 225Ac-PSMA-617 |b swimmer-plot analysis suggests efficacy regarding duration of tumor control |c Clemens Kratochwil, Frank Bruchertseifer, Hendrik Rathke, Markus Hohenfellner, Frederik L. Giesel, Uwe Haberkorn, and Alfred Morgenstern |
| 264 | 1 | |c Jan. 11, 2018 | |
| 300 | |a 9 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Im Titel erscheint die Ziffernfolge 225 hochgestellt | ||
| 500 | |a Gesehen am 16.04.2020 | ||
| 520 | |a The aim of this evaluation was to identify the first indicators of efficacy for 225Ac-labeled prostate-specific membrane antigen (PSMA)-617 therapy in a retrospectively analyzed group of patients. | ||
| 650 | 4 | |a 225Ac | |
| 650 | 4 | |a Ac-225 | |
| 650 | 4 | |a prostate cancer | |
| 650 | 4 | |a PSMA | |
| 650 | 4 | |a targeting therapy | |
| 700 | 1 | |a Bruchertseifer, Frank |e VerfasserIn |4 aut | |
| 700 | 1 | |a Rathke, Hendrik |d 1986- |e VerfasserIn |0 (DE-588)1151445495 |0 (DE-627)1011715392 |0 (DE-576)497748223 |4 aut | |
| 700 | 1 | |a Hohenfellner, Markus |d 1958- |e VerfasserIn |0 (DE-588)133862518 |0 (DE-627)557857988 |0 (DE-576)300155263 |4 aut | |
| 700 | 1 | |a Giesel, Frederik L. |d 1970- |e VerfasserIn |0 (DE-588)129031240 |0 (DE-627)387883878 |0 (DE-576)297457071 |4 aut | |
| 700 | 1 | |a Haberkorn, Uwe |d 1959- |e VerfasserIn |0 (DE-588)1022913905 |0 (DE-627)717331245 |0 (DE-576)366166352 |4 aut | |
| 700 | 1 | |a Morgenstern, Alfred |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of nuclear medicine |d New York, NY : Soc., 1964 |g 59(2018), 5, Seite 795-802 |h Online-Ressource |w (DE-627)325793603 |w (DE-600)2040222-3 |w (DE-576)09475277X |x 2159-662X |7 nnas |a Targeted α-therapy of metastatic castration-resistant prostate cancer with 225Ac-PSMA-617 swimmer-plot analysis suggests efficacy regarding duration of tumor control |
| 773 | 1 | 8 | |g volume:59 |g year:2018 |g number:5 |g pages:795-802 |g extent:9 |a Targeted α-therapy of metastatic castration-resistant prostate cancer with 225Ac-PSMA-617 swimmer-plot analysis suggests efficacy regarding duration of tumor control |
| 856 | 4 | 0 | |u https://doi.org/10.2967/jnumed.117.203539 |x Resolving-System |x Verlag |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u http://jnm.snmjournals.org/content/59/5/795 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20200416 | ||
| 993 | |a Article | ||
| 994 | |a 2018 | ||
| 998 | |g 1022913905 |a Haberkorn, Uwe |m 1022913905:Haberkorn, Uwe |d 910000 |d 911400 |e 910000PH1022913905 |e 911400PH1022913905 |k 0/910000/ |k 1/910000/911400/ |p 6 | ||
| 998 | |g 129031240 |a Giesel, Frederik L. |m 129031240:Giesel, Frederik L. |d 910000 |d 911400 |e 910000PG129031240 |e 911400PG129031240 |k 0/910000/ |k 1/910000/911400/ |p 5 | ||
| 998 | |g 133862518 |a Hohenfellner, Markus |m 133862518:Hohenfellner, Markus |d 910000 |d 910200 |e 910000PH133862518 |e 910200PH133862518 |k 0/910000/ |k 1/910000/910200/ |p 4 | ||
| 998 | |g 1151445495 |a Rathke, Hendrik |m 1151445495:Rathke, Hendrik |d 910000 |d 911400 |e 910000PR1151445495 |e 911400PR1151445495 |k 0/910000/ |k 1/910000/911400/ |p 3 | ||
| 998 | |g 134026276 |a Kratochwil, Clemens |m 134026276:Kratochwil, Clemens |d 910000 |d 911400 |e 910000PK134026276 |e 911400PK134026276 |k 0/910000/ |k 1/910000/911400/ |p 1 |x j | ||
| 999 | |a KXP-PPN1694741257 |e 3624370987 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"physDesc":[{"extent":"9 S."}],"id":{"doi":["10.2967/jnumed.117.203539"],"eki":["1694741257"]},"title":[{"title":"Targeted α-therapy of metastatic castration-resistant prostate cancer with 225Ac-PSMA-617","subtitle":"swimmer-plot analysis suggests efficacy regarding duration of tumor control","title_sort":"Targeted α-therapy of metastatic castration-resistant prostate cancer with 225Ac-PSMA-617"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"origin":[{"dateIssuedKey":"2018","dateIssuedDisp":"Jan. 11, 2018"}],"relHost":[{"note":["Gesehen am 13.12.2021"],"pubHistory":["Nachgewiesen 5.1964 -"],"language":["eng"],"part":{"issue":"5","extent":"9","pages":"795-802","text":"59(2018), 5, Seite 795-802","volume":"59","year":"2018"},"titleAlt":[{"title":"JNM"}],"disp":"Targeted α-therapy of metastatic castration-resistant prostate cancer with 225Ac-PSMA-617 swimmer-plot analysis suggests efficacy regarding duration of tumor controlJournal of nuclear medicine","type":{"media":"Online-Ressource","bibl":"periodical"},"corporate":[{"role":"isb","display":"Society of Nuclear Medicine"}],"recId":"325793603","name":{"displayForm":["Society of Nuclear Medicine"]},"origin":[{"dateIssuedDisp":"1964-","publisher":"Soc.","publisherPlace":"New York, NY","dateIssuedKey":"1964"}],"title":[{"title_sort":"Journal of nuclear medicine","title":"Journal of nuclear medicine","subtitle":"JNM"}],"id":{"zdb":["2040222-3"],"eki":["325793603"],"issn":["2159-662X","1535-5667"]},"physDesc":[{"extent":"Online-Ressource"}]}],"language":["eng"],"name":{"displayForm":["Clemens Kratochwil, Frank Bruchertseifer, Hendrik Rathke, Markus Hohenfellner, Frederik L. Giesel, Uwe Haberkorn, and Alfred Morgenstern"]},"note":["Im Titel erscheint die Ziffernfolge 225 hochgestellt","Gesehen am 16.04.2020"],"person":[{"given":"Clemens","display":"Kratochwil, Clemens","role":"aut","family":"Kratochwil"},{"display":"Bruchertseifer, Frank","given":"Frank","family":"Bruchertseifer","role":"aut"},{"given":"Hendrik","display":"Rathke, Hendrik","role":"aut","family":"Rathke"},{"given":"Markus","display":"Hohenfellner, Markus","family":"Hohenfellner","role":"aut"},{"display":"Giesel, Frederik L.","given":"Frederik L.","role":"aut","family":"Giesel"},{"given":"Uwe","display":"Haberkorn, Uwe","role":"aut","family":"Haberkorn"},{"given":"Alfred","display":"Morgenstern, Alfred","role":"aut","family":"Morgenstern"}],"recId":"1694741257"} | ||
| SRT | |a KRATOCHWILTARGETEDTH1120 | ||